Literature DB >> 15800039

Conformational transition of amyloid beta-peptide.

Yechun Xu1, Jianhua Shen, Xiaomin Luo, Weiliang Zhu, Kaixian Chen, Jianpeng Ma, Hualiang Jiang.   

Abstract

The amyloid beta-peptides (Abetas), containing 39-43 residues, are the key protein components of amyloid deposits in Alzheimer's disease. To structurally characterize the dynamic behavior of Abeta(40), 12 independent long-time molecular dynamics (MD) simulations for a total of 850 ns were performed on both the wide-type peptide and its mutant in both aqueous solution and a biomembrane environment. In aqueous solution, an alpha-helix to beta-sheet conformational transition for Abeta(40) was observed, and an entire unfolding process from helix to coil was traced by MD simulation. Structures with beta-sheet components were observed as intermediates in the unfolding pathway of Abeta(40). Four glycines (G(25), G(29), G(33), and G(37)) are important for Abeta(40) to form beta-sheet in aqueous solution; mutations of these glycines to alanines almost abolished the beta-sheet formation and increased the content of the helix component. In the dipalmitoyl phosphatidylcholine (DPPC) bilayer, the major secondary structure of Abeta(40) is a helix; however, the peptide tends to exit the membrane environment and lie down on the surface of the bilayer. The dynamic feature revealed by our MD simulations rationalized several experimental observations for Abeta(40) aggregation and amyloid fibril formation. The results of MD simulations are beneficial to understanding the mechanism of amyloid formation and designing the compounds for inhibiting the aggregation of Abeta and amyloid fibril formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15800039      PMCID: PMC556260          DOI: 10.1073/pnas.0501218102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.

Authors:  P H Weinreb; W Zhen; A W Poon; K A Conway; P T Lansbury
Journal:  Biochemistry       Date:  1996-10-29       Impact factor: 3.162

2.  Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.

Authors:  M F Walter; P E Mason; R P Mason
Journal:  Biochem Biophys Res Commun       Date:  1997-04-28       Impact factor: 3.575

3.  Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature.

Authors:  O Berger; O Edholm; F Jähnig
Journal:  Biophys J       Date:  1997-05       Impact factor: 4.033

4.  Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice.

Authors:  U Igbavboa; N A Avdulov; F Schroeder; W G Wood
Journal:  J Neurochem       Date:  1996-04       Impact factor: 5.372

5.  Aggregation state-dependent binding of beta-amyloid peptide to protein and lipid components of rat cortical homogenates.

Authors:  T A Good; R M Murphy
Journal:  Biochem Biophys Res Commun       Date:  1995-02-06       Impact factor: 3.575

6.  Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix.

Authors:  C Blake; L Serpell
Journal:  Structure       Date:  1996-08-15       Impact factor: 5.006

7.  1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence.

Authors:  J P Lee; E R Stimson; J R Ghilardi; P W Mantyh; Y A Lu; A M Felix; W Llanos; A Behbin; M Cummings; M Van Criekinge
Journal:  Biochemistry       Date:  1995-04-18       Impact factor: 3.162

8.  Alamethicin helices in a bilayer and in solution: molecular dynamics simulations.

Authors:  D P Tieleman; M S Sansom; H J Berendsen
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

9.  Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease.

Authors:  H Sticht; P Bayer; D Willbold; S Dames; C Hilbich; K Beyreuther; R W Frank; P Rösch
Journal:  Eur J Biochem       Date:  1995-10-01

10.  Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.

Authors:  C J Pike; A J Walencewicz-Wasserman; J Kosmoski; D H Cribbs; C G Glabe; C W Cotman
Journal:  J Neurochem       Date:  1995-01       Impact factor: 5.372

View more
  57 in total

1.  Distinguishing amyloid fibril structures in Alzheimer's disease (AD) by two-dimensional ultraviolet (2DUV) spectroscopy.

Authors:  A R Lam; J Jiang; S Mukamel
Journal:  Biochemistry       Date:  2011-10-20       Impact factor: 3.162

2.  Solvent and mutation effects on the nucleation of amyloid beta-protein folding.

Authors:  Luis Cruz; Brigita Urbanc; Jose M Borreguero; Noel D Lazo; David B Teplow; H Eugene Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

3.  Protofibril assemblies of the arctic, Dutch, and Flemish mutants of the Alzheimer's Abeta1-40 peptide.

Authors:  Nicolas Lux Fawzi; Kevin L Kohlstedt; Yuka Okabe; Teresa Head-Gordon
Journal:  Biophys J       Date:  2007-11-21       Impact factor: 4.033

Review 4.  Computational simulations of the early steps of protein aggregation.

Authors:  Guanghong Wei; Normand Mousseau; Philippe Derreumaux
Journal:  Prion       Date:  2007-01-05       Impact factor: 3.931

5.  Microsecond molecular dynamics simulation of Aβ42 and identification of a novel dual inhibitor of Aβ42 aggregation and BACE1 activity.

Authors:  Yuan-yuan Wang; Li Li; Tian-tian Chen; Wu-yan Chen; Ye-chun Xu
Journal:  Acta Pharmacol Sin       Date:  2013-06-17       Impact factor: 6.150

Review 6.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

7.  Development of multifunctional heterocyclic Schiff base as a potential metal chelator: a comprehensive spectroscopic approach towards drug discovery.

Authors:  Manojkumar Jadhao; Chayan Das; Anoop Rawat; Himank Kumar; Ritika Joshi; Sudipta Maiti; Sujit Kumar Ghosh
Journal:  J Biol Inorg Chem       Date:  2016-11-07       Impact factor: 3.358

8.  Scaling and alpha-helix regulation of protein relaxation in a lipid bilayer.

Authors:  Liming Qiu; Creighton Buie; Kwan Hon Cheng; Mark W Vaughn
Journal:  J Chem Phys       Date:  2014-12-14       Impact factor: 3.488

9.  Interaction between amyloid-beta (1-42) peptide and phospholipid bilayers: a molecular dynamics study.

Authors:  Charles H Davis; Max L Berkowitz
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

10.  The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?

Authors:  Kerensa Broersen; Frederic Rousseau; Joost Schymkowitz
Journal:  Alzheimers Res Ther       Date:  2010-07-14       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.